Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
Institutions: University of Naples Federico II, Innsbruck Medical University, Universität Innsbruck, Boehringer Ingelheim (Germany), Boehringer Ingelheim (France), Boehringer Ingelheim (United Kingdom), Inserm, Centre Hospitalier Universitaire de Toulouse, Toulouse NeuroImaging Center, Biomedical Research Networking Center on Neurodegenerative Diseases, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Mental Illness Research, Education and Clinical Centers, Philadelphia VA Medical Center, University of Pennsylvania
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Boehringer Ingelheim
OpenAlex ID: W2152837663